Genotoxicity profile of fexinidazolea drug candidate in clinical development for human African trypanomiasis (sleeping sickness)

By Tweats David   Torreele Els  

Mutagenesis, Vol. 27, Iss. 5, 2012-09 ,pp. : 523-532

Oxford University Press

Access to resources Recommend Favorite

Eukaryotic lipid-biosynthetic enzymes: the same but not the same

By Vance J.E.  

Trends in Biochemical Sciences, Vol. 23, Iss. 11, 1998-11 ,pp. : 423-428

Elsevier

Access to resources Recommend Favorite

Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease

By  

Current Enzyme Inhibition, Vol. 6, Iss. 4, 2010-01 ,pp. : 183-194

Bentham Science Publishers

Access to resources Recommend Favorite

Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention

By Gerner E. W.   Meyskens F. L.   Goldschmid S.   Lance P.   Pelot D.  

Amino Acids, Vol. 33, Iss. 2, 2007-08 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness

By Glinma Bienvenu   Kpoviessi Sika   Gbaguidi Fernand   Kapanda Coco   Bero Joanne   Quetin-Leclercq Joëlle   Moudachirou Mansourou   Poupaert Jacques   Accrombessi Georges   Gachomo Emma   Baba-Moussa Lamine   Kotchoni Simeon  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1617-1622

Springer Publishing Company

Access to resources Recommend Favorite